Updated guidelines recommend fidaxomicin as the first-line agent for C difficile infection, but researchers found use in US ...

The Food and Drug Administration (FDA) has expanded the approval of Bimzelx ® (bimekizumab-bkzx) to include 3 new indications. In addition to plaque psoriasis, Bimzelx, a humanized interleukin-17A and ...

The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of ...

The global health organization says the lack of rapid diagnostic tests results in undertreatment and overtreatment of ...

Delayed vs timely antiviral treatment initiation in adults hospitalized with influenza-associated pneumonia is linked to higher mortality risk.

Does cancer spread from one individual to another? An oncologist offers insightful knowledge on childhood cancer, dispelling ...

Researchers investigated characteristics of adolescent and young adult patients with HCC and risk factors that affect survival.

The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...

SIADH (syndrome of inappropriate antidiuretic hormone secretion) leads to hyponatremia water retention in hospitalized or ...

The Sanjay Gandhi Postgraduate Institute of Medical Sciences in Lucknow has reached a milestone of 500 robotic urology ...

Eli Lilly's Ebglyss gains FDA approval for atopic dermatitis treatment, poised to rival Dupixent with strong performance in ...